Peter Nielsen
Vorstandsvorsitzender bei BIO-PATH HOLDINGS, INC.
Vermögen: 2 662 $ am 31.05.2024
Profil
Peter H.
Nielsen is the founder of Bio-Path, Inc. (founded in 2007) and Bio-Path Holdings, Inc. (founded in 2007), where he holds the titles of Chairman, President, CEO, CFO & Treasurer.
He has also worked as a Director at Synthecon, Inc. and as the Chief Financial Officer at OMNI Energy Services Corp.
Mr. Nielsen obtained his undergraduate degree and MBA from the University of California, Berkeley.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
BIO-PATH HOLDINGS, INC.
0,08% | 05.03.2024 | 1 292 ( 0,08% ) | 2 662 $ | 31.05.2024 |
Aktive Positionen von Peter Nielsen
| Unternehmen | Position | Beginn |
|---|---|---|
| BIO-PATH HOLDINGS, INC. | Vorstandsvorsitzender | 01.01.2008 |
Bio-Path, Inc.
 Bio-Path, Inc. Pharmaceuticals: MajorHealth Technology Bio-Path, Inc. develops pharmaceutical drugs. It is a development stage company and operates in novel cancer therapeutics. Bio-Path was founded in 2007 by Gabriel Lopez Berestein, Peter Nielsen and Douglas P. Morris and is located in Ogden, UT | Vorstandsvorsitzender | - |
Ehemalige bekannte Positionen von Peter Nielsen
| Unternehmen | Position | Ende |
|---|---|---|
OMNI Energy Services Corp.
 OMNI Energy Services Corp. Contract DrillingIndustrial Services OMNI Energy Services Corp. provides oilfield services. It operates various operating segments that includes equipment leasing, drilling and completion fluids, environmental services, transportation and disposal, and seismic drilling. The company was founded on September 12, 1997 and is headquartered in Carencro, LA. | Finanzdirektor/CFO | - |
Synthecon, Inc.
 Synthecon, Inc. BiotechnologyHealth Technology Synthecon, Inc. engages in the biotechnology industry. The firm specializes in in the design and manufacture of 3D cell culture systems. Its products include phenodrive, RCCS 3D cell culture systems, stem cell culture, perfusion bioreactors, custom designed bioreactors, nanobiomatrix scaffolds, and biostructure matrix scaffolds. The company was founded by Charles D. Anderson and Ray Schwarz in 1990 and is headquartered in Houston, TX. | Direktor/Vorstandsmitglied | - |
Ausbildung von Peter Nielsen
| University of California, Berkeley | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| BIO-PATH HOLDINGS, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Bio-Path, Inc.
Bio-Path, Inc. Pharmaceuticals: MajorHealth Technology Bio-Path, Inc. develops pharmaceutical drugs. It is a development stage company and operates in novel cancer therapeutics. Bio-Path was founded in 2007 by Gabriel Lopez Berestein, Peter Nielsen and Douglas P. Morris and is located in Ogden, UT | Health Technology |
Synthecon, Inc.
Synthecon, Inc. BiotechnologyHealth Technology Synthecon, Inc. engages in the biotechnology industry. The firm specializes in in the design and manufacture of 3D cell culture systems. Its products include phenodrive, RCCS 3D cell culture systems, stem cell culture, perfusion bioreactors, custom designed bioreactors, nanobiomatrix scaffolds, and biostructure matrix scaffolds. The company was founded by Charles D. Anderson and Ray Schwarz in 1990 and is headquartered in Houston, TX. | Health Technology |
OMNI Energy Services Corp.
OMNI Energy Services Corp. Contract DrillingIndustrial Services OMNI Energy Services Corp. provides oilfield services. It operates various operating segments that includes equipment leasing, drilling and completion fluids, environmental services, transportation and disposal, and seismic drilling. The company was founded on September 12, 1997 and is headquartered in Carencro, LA. | Industrial Services |
